AZANTA DANMARK AS has a total of 15 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals are GP PHARM SA, PELLEPHARM INC and THERAMARK LIMITED.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Hungary | 1 | |
#7 | Jordan | 1 | |
#8 | Japan | 1 | |
#9 | Morocco | 1 | |
#10 | Mexico | 1 | |
#11 | New Zealand | 1 | |
#12 | Tunisia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Selvaraj Sekar | 9 |
#2 | Arunachalam Malaiarasan | 9 |
#3 | Venugopal Prabhakaran | 9 |
#4 | Elumalai Baskar | 9 |
#5 | Prabhakaran Venugopal | 6 |
#6 | Sekar Selvaraj | 6 |
#7 | Baskar Elumalai | 6 |
#8 | Malaiarasan Arunachalam | 6 |
Publication | Filing date | Title |
---|---|---|
JO3321B1 | Misoprostol Dispersible Tablet | |
NZ727876A | Misoprostol dispersible tablet | |
EP2965750A1 | Misoprostol dispersible tablet |